National Advisory Committee on Immunization (NACI)

National Advisory Committee on Immunization (NACI): Statements and publications

NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable diseases for whom vaccination should be targeted. NACI knowledge syntheses, analyses and recommendations on vaccine use in Canada are published in literature reviews, statements and updates.

New statements are those which have been published within the past five years. Previous statements are those which are were published over five years ago and have been archived.

NACI recommendations are also published in vaccine-specific chapters of the Canadian Immunization Guide.

• NEW! NACI Recommendations on the Use of COVID-19 Vaccine
• NOUVEAU! CCNI Recommandations sur l'utilisation des vaccins contre la COIVD-19

• Recommendations on the Duration of the Post-vaccination Observation Period for Influenza Vaccination during the COVID-19 Pandemic

• Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals

• NACI Research Priorities for COVID-19 Vaccines to Support Public Health Decisions

• Interim guidance on continuity of immunization programs during the COVID-19 pandemic

• Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2020–2021

Email updates are available through our mailing list. To subscribe to receive instant alerts when chapter updates and new NACI products are posted.